- In a post-market announcement last night, Novavax (NASDAQ:NVAX) said they have delayed trials of their influenza vaccine until 2013 after the FDA denied fast-track status … Continue Reading
Read now- This morning, Idenix Pharmaceuticals (NASDAQ:IDIX) announced that the FDA has granted Fast-Track status to their development-stage hepatitis C (HCV) treatment IDX719. The drug is an … Continue Reading
Read nowLong Ideas - Nuvo Research Inc. announced that the U.S. Patent and Trade Office (PTO) reinstated a patent protecting the company’s Synera Patch through July 2020. Synera is … Continue Reading
Read now- Up 5% in early trading this morning, Spectrum Pharmaceuticals (NASDAQ:SPPI) is seeing action on sales growth expectations of its colon cancer drug Fusilev. According to … Continue Reading
Read now- Bristol-Myers Squibb (NYSE:BMY) reported its second quarter results this morning, with an 18% loss in revenue from last year to $4.44B, and net income of … Continue Reading
Read nowResearch - Regulatory changes are about to impose significant pressures upon the growth of a major medical equipment manufacturer – to the tune of 30% or more.
Read now- BioCryst Pharmaceuticals (NASDAQ:BCRX) announced this morning that its Phase 2b trial of ulodesine, in tandem with allopurinol, had favorable safety and sustained efficacy in extended … Continue Reading
Read now